Articles

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 4

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 4

- [field_author]

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 4 Project Lead -- Ullas Kolthur and Sandeep Juneja Interviewers -- Uma Ramakrishnan (NCBS) and Meena Kharatmal (HBCSE-TIFR)

 

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 3

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 3

- [field_author]

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 3 Project Lead -- Ullas Kolthur and Sandeep Juneja Interviewers -- Uma Ramakrishnan (NCBS) and Meena Kharatmal (HBCSE-TIFR)

 

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 2

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 2

- [field_author]

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 2 Project Lead -- Ullas Kolthur and Sandeep Juneja Interviewers -- Meena Kharatmal (HBCSE-TIFR) and Uma Ramakrishnan (NCBS)

 

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 1

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 1

- [field_author]

Seroprevalence Study in Mumbai: In Conversation with TIFR Scientists -- Part 1 Project Lead -- Ullas Kolthur and Sandeep Juneja Interviewers -- Meena Kharatmal (HBCSE-TIFR) and Uma Ramakrishnan (NCBS)

 

Public health framework and its intersections with society while dealing with the pandemic -- A conversation with a public health care specialist

Public health framework and its intersections with society while dealing with the pandemic -- A conversation with a public health care specialist

- [field_author]

Dr. Rakhal Gaitonde, a medical doctor and a PhD in public health, discusses the challenges of working with the public health care system during the pandemic, and calls for a proactive interaction of scientists in interfacing with policymakers, along with community engagement.

 

How do infections jump from animals to humans?

How do infections jump from animals to humans?

- [field_author]

An interview with Uma Ramakrishnan where she discusses how evolutionary approaches can be used to better understand zoonoses, and the transmission of the coronavirus to other animals, including tigers and pet cats and dogs.

 

Being a scientist in the post-COVID world: In conversation with LS Shashidhara

Being a scientist in the post-COVID world: In conversation with LS Shashidhara

- [field_author]

The COVID-19 pandemic has brought science and scientists to the forefront of public scrutiny. At the same time, it has forced many scientists to take a step back and introspect as lockdown procedures are implemented throughout the country. We spoke to LS Shashidhara, Professor, Indian Institute of Science Education and Research (IISER) Pune (Currently, on Lien at Ashoka University), about the impact the current situation has had on the way scientific research is conducted in our country, and the lessons scientists can take away from it for the future.

 

COVID-19 in rural India ‒ a public health perspective

COVID-19 in rural India ‒ a public health perspective

- [field_author]

In this Q&A with Vanshika Singh, public health researcher Yogeshwar Kalkonde takes us through the challenges posed by the COVID-19 pandemic for those at the fringes of healthcare ‒ the rural Indian population.

 

Rising to the challenge: Startups and the COVID-19 crisis

Rising to the challenge: Startups and the COVID-19 crisis

- [field_author]

In this Q&A, Amitabha Bandyopadhyay describes how startups in India have risen to the challenge of providing COVID-19 solutions, highlighting the example of Nocca Robotics, a startup that swiftly developed a low-cost ventilator in record time.

 

CSIR’s role in COVID-19 crisis

CSIR’s role in COVID-19 crisis

- [field_author]

The Council of Scientific and Industrial Research (CSIR) is the largest publicly funded R&D organization in the country. We spoke to Dr. Shekhar C. Mande, the Director General, about CSIR’s role in the COVID-19 crisis. In this “as told to” article, Dr. Mande outlines the various strategies and efforts being undertaken in CSIR labs to combat the pandemic.

 

Candidate Therapeutics for COVID-19: Current Scenario and Future Possibilities

Candidate Therapeutics for COVID-19: Current Scenario and Future Possibilities

- [field_author]

Dr. Karishma Kaushik answers five pressing questions on the current search for candidate therapeutics that can combat the COVID-19 infection.

 

Coronavirus disease (COVID-19): Frequently Asked Questions

Coronavirus disease (COVID-19): Frequently Asked Questions

- [field_author]

In the wake of the present global pandemic, there has been a rapid proliferation of misinformation and rumours related to coronavirus infection and disease, particularly via social media. We requested Gautam Menon, Professor of Physics and Biology at Ashoka University, Sonipat and Institute of Mathematical Sciences, Chennai, to answer some of the most common questions being asked about the virus and clear up some misconceptions.